Clinical Trials
2 trialsNCT02337309 2018-08-20
SF1126 for Patients With Relapsed or Refractory Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Terminated
NCT02644122 2018-07-11
SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes
University of California, San Diego
Phase 2 Terminated